tiprankstipranks
Trending News
More News >
Kiniksa Pharmaceuticals (KNSA)
NASDAQ:KNSA
US Market

Kiniksa Pharmaceuticals (KNSA) Revenue

Compare
450 Followers

Kiniksa Pharmaceuticals Revenue

Kiniksa Pharmaceuticals had a revenue of 122.54M in the quarter ending Dec 31, 2024, with 9.20%. This bring the company's revenue in the last twelve months to 423.24M, Decreased 10.19%. In the fiscal year ending Dec 31, 2024, Kiniksa Pharmaceuticals had annual revenue of 423.24M with 56.60% growth.
Revenue (ttm)
423.24M
Revenue Growth
56.60%
P/S Ratio
3.31
Revenue/Employee
$1,343,616
Employees
315
Market Cap
$1.40B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024423.24M152.98M+56.60%
Dec 31, 2023270.26M50.08M+22.74%
Dec 31, 2022220.18M181.64M+471.24%
Dec 31, 202138.54M+∞%
Dec 31, 20200.00
Dec 31, 20190.00
Dec 31, 20180.00
Dec 31, 20170.00
Dec 31, 20160.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis